Seoul Hospital
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi) (NCT06296056) | Seoul Hospital | 2024-08-01 |
Track Seoul Hospital automatically
Every clearance here is in the API, with alerts when new ones post.